Tag: FOLD stock

Analysts Viewpoint

Amicus Therapeutics Inc [FOLD] President and CEO makes an insider purchase of 7,500 shares worth 79492.0.

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Amicus Therapeutics

Analysts Viewpoint

Checking in on Amicus Therapeutics Inc (FOLD) after recent insiders movement

Amicus Therapeutics Inc’s recent filing unveils that its President and CEO Campbell Bradley L unloaded Company’s shares for reported $79492.0

Analysts Viewpoint

Amicus Therapeutics Inc [FOLD] Shares Fall Approximately -3.99% Over the Year

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its